Join

Compare · ABT vs ANIP

ABT vs ANIP

Side-by-side comparison of Abbott Laboratories (ABT) and ANI Pharmaceuticals Inc. (ANIP): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ABT and ANIP operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • ABT is the larger of the two at $158.63B, about 87.1x ANIP ($1.82B).
  • Over the past year, ABT is down 32.2% and ANIP is up 26.8% - ANIP leads by 59.0 points.
  • ABT has been more active in the news (6 items in the past 4 weeks vs 2 for ANIP).
  • ABT has more recent analyst coverage (25 ratings vs 11 for ANIP).
PerformanceABT-32.20%ANIP+26.81%
2025-06-09+0.00%2026-06-08
MetricABTANIP
Company
Abbott Laboratories
ANI Pharmaceuticals Inc.
Price
$90.44-0.69%
$80.13-1.14%
Market cap
$158.63B
$1.82B
1M return
+4.00%
-4.70%
1Y return
-32.20%
+26.81%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NYSE
NASDAQ
IPO
News (4w)
6
2
Recent ratings
25
11
ABT

Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.

ANIP

ANI Pharmaceuticals Inc.

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.

Latest ABT

Latest ANIP